[HTML][HTML] SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs
AX Han, A Toporowski, JA Sacks, MD Perkins… - Nature Genetics, 2023 - nature.com
The first step in SARS-CoV-2 genomic surveillance is testing to identify people who are
infected. However, global testing rates are falling as we emerge from the acute health …
infected. However, global testing rates are falling as we emerge from the acute health …
SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs
AX Han, A Toporowski, JA Sacks… - Nature …, 2023 - researchinformation.amsterdamumc …
The first step in SARS-CoV-2 genomic surveillance is testing to identify people who are
infected. However, global testing rates are falling as we emerge from the acute health …
infected. However, global testing rates are falling as we emerge from the acute health …
SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs
AX Han, A Toporowski, JA Sacks… - Nature …, 2023 - pubmed.ncbi.nlm.nih.gov
The first step in SARS-CoV-2 genomic surveillance is testing to identify people who are
infected. However, global testing rates are falling as we emerge from the acute health …
infected. However, global testing rates are falling as we emerge from the acute health …
SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs.
AX Han, A Toporowski, JA Sacks, MD Perkins, S Briand… - 2023 - cabidigitallibrary.org
The first step in SARS-CoV-2 genomic surveillance is testing to identify people who are
infected. However, global testing rates are falling as we emerge from the acute health …
infected. However, global testing rates are falling as we emerge from the acute health …
[HTML][HTML] SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs
AX Han, A Toporowski, JA Sacks, MD Perkins, S Briand… - 2022 - europepmc.org
The first step in SARS-CoV-2 genomic surveillance is testing to identify infected people.
However, global testing rates are falling as we emerge from the acute health emergency and …
However, global testing rates are falling as we emerge from the acute health emergency and …
[PDF][PDF] SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs
AX Han, A Toporowski, JA Sacks, MD Perkins… - Nature …, 2023 - scienceopen.com
The first step in SARS-CoV-2 genomic surveillance is testing to identify people who are
infected. However, global testing rates are falling as we emerge from the acute health …
infected. However, global testing rates are falling as we emerge from the acute health …
[HTML][HTML] SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs
AX Han, A Toporowski, JA Sacks, MD Perkins… - Nature …, 2023 - ncbi.nlm.nih.gov
The first step in SARS-CoV-2 genomic surveillance is testing to identify people who are
infected. However, global testing rates are falling as we emerge from the acute health …
infected. However, global testing rates are falling as we emerge from the acute health …
[HTML][HTML] SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs
AX Han, A Toporowski, JA Sacks, MD Perkins, S Briand… - medRxiv - ncbi.nlm.nih.gov
The first step in SARS-CoV-2 genomic surveillance is testing to identify infected people.
However, global testing rates are falling as we emerge from the acute health emergency and …
However, global testing rates are falling as we emerge from the acute health emergency and …
SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs
AX Han, A Toporowski, JA Sacks… - … : the preprint server …, 2022 - pubmed.ncbi.nlm.nih.gov
The first step in SARS-CoV-2 genomic surveillance is testing to identify infected people.
However, global testing rates are falling as we emerge from the acute health emergency and …
However, global testing rates are falling as we emerge from the acute health emergency and …
SARS-CoV-2 diagnostic testing rates determine the sensitivity of genomic surveillance programs.
AX Han, A Toporowski, JA Sacks, MD Perkins… - Nature …, 2023 - europepmc.org
The first step in SARS-CoV-2 genomic surveillance is testing to identify people who are
infected. However, global testing rates are falling as we emerge from the acute health …
infected. However, global testing rates are falling as we emerge from the acute health …